XCELLA BIOSCIENCES Trademark

Trademark Overview

On Monday, October 19, 2015, a trademark application was filed for XCELLA BIOSCIENCES with the United States Patent and Trademark Office. The USPTO has given the XCELLA BIOSCIENCES trademark a serial number of 86792506. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 10, 2024. This trademark is owned by xCella Biosciences, Inc.. The XCELLA BIOSCIENCES trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:

Custom manufacturing services in the nature of biomanufacturing for others, namely, manufacturing of pharmaceuticals using biological organisms in the manufacturing process featuring synthesis and assembly of nucleic acids, peptides, proteins, cells, nucleic acid arrays, peptide arrays, and protein arrays; providing technical information in the field of pharmaceutical manufacturing specifically relating to proteins, enzymes, and pharmaceutical compounds and their manufacturing processes

Consulting services in the fields of biotechnology, pharmaceutical research and development and design and development of proteins, enzymes, biologics, and drug formulations; scientific and technological services, namely, research in the fields of chemistry and molecular biology, namely, protein and biologics detection, characterization, analysis and testing; research and development services in connection with the design, synthesis and assembly of nucleic acids, peptides, proteins, cells, nucleic acid arrays, peptide arrays, and protein arrays
xcella biosciences

General Information

Serial Number86792506
Word MarkXCELLA BIOSCIENCES
Filing DateMonday, October 19, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 10, 2024
Registration Number5324410
Registration DateTuesday, October 31, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 27, 2016

Trademark Statements

Goods and ServicesCustom manufacturing services in the nature of biomanufacturing for others, namely, manufacturing of pharmaceuticals using biological organisms in the manufacturing process featuring synthesis and assembly of nucleic acids, peptides, proteins, cells, nucleic acid arrays, peptide arrays, and protein arrays; providing technical information in the field of pharmaceutical manufacturing specifically relating to proteins, enzymes, and pharmaceutical compounds and their manufacturing processes
NOT AVAILABLE"BIOSCIENCES"
Goods and ServicesConsulting services in the fields of biotechnology, pharmaceutical research and development and design and development of proteins, enzymes, biologics, and drug formulations; scientific and technological services, namely, research in the fields of chemistry and molecular biology, namely, protein and biologics detection, characterization, analysis and testing; research and development services in connection with the design, synthesis and assembly of nucleic acids, peptides, proteins, cells, nucleic acid arrays, peptide arrays, and protein arrays

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 10, 2024
Primary Code040
First Use Anywhere DateThursday, May 19, 2016
First Use In Commerce DateThursday, May 19, 2016
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 10, 2024
Primary Code042
First Use Anywhere DateThursday, May 19, 2016
First Use In Commerce DateThursday, May 19, 2016

Trademark Owner History

Party NamexCella Biosciences, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressEmeryville, CA 94608
Party NamexCella Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025
Party NamexCella Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025

Trademark Events

Event DateEvent Description
Tuesday, February 16, 2016NON-FINAL ACTION WRITTEN
Thursday, October 22, 2015NEW APPLICATION ENTERED
Friday, October 23, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 9, 2016ASSIGNED TO EXAMINER
Tuesday, February 16, 2016NON-FINAL ACTION E-MAILED
Tuesday, February 16, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 22, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, August 8, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 8, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 9, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 15, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 7, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 27, 2016PUBLISHED FOR OPPOSITION
Tuesday, September 27, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Saturday, June 17, 2017NON-FINAL ACTION E-MAILED
Thursday, April 13, 2017SOU TEAS EXTENSION RECEIVED
Thursday, April 13, 2017SOU EXTENSION 1 FILED
Thursday, April 13, 2017SOU EXTENSION 1 GRANTED
Saturday, April 15, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 26, 2017TEAS STATEMENT OF USE RECEIVED
Wednesday, April 26, 2017USE AMENDMENT FILED
Friday, May 19, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, May 22, 2017STATEMENT OF USE PROCESSING COMPLETE
Saturday, June 17, 2017SU - NON-FINAL ACTION - WRITTEN
Saturday, June 17, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 31, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, November 10, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 25, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 7, 2017ASSIGNED TO LIE
Friday, September 8, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 8, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 27, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, September 28, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 10, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, November 5, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 5, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, November 5, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, November 5, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 31, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, February 16, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 10, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 10, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 10, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, November 5, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 16, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 16, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, February 16, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 16, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 10, 2024CANCELLED SEC. 8 (6-YR)

Related Keywords

biosciences xcella arrays manufacturing proteins nucleic services pharmaceutical protein development research namely